Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiosurgery | 8 | 2024 | 1343 | 2.140 |
Why?
|
Particle Accelerators | 3 | 2018 | 174 | 1.650 |
Why?
|
Radiometry | 7 | 2017 | 813 | 1.440 |
Why?
|
Radiotherapy Dosage | 7 | 2024 | 2897 | 1.290 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 8 | 2024 | 1660 | 1.140 |
Why?
|
Four-Dimensional Computed Tomography | 1 | 2024 | 144 | 0.850 |
Why?
|
Radiotherapy | 3 | 2019 | 1505 | 0.830 |
Why?
|
Neutrons | 1 | 2018 | 77 | 0.590 |
Why?
|
Europium | 3 | 2014 | 13 | 0.550 |
Why?
|
Scattering, Radiation | 1 | 2017 | 488 | 0.520 |
Why?
|
Potassium Chloride | 3 | 2014 | 233 | 0.520 |
Why?
|
Photons | 2 | 2018 | 581 | 0.520 |
Why?
|
Phantoms, Imaging | 4 | 2019 | 2510 | 0.510 |
Why?
|
Radiation Protection | 1 | 2018 | 425 | 0.460 |
Why?
|
Radiotherapy, Intensity-Modulated | 3 | 2019 | 801 | 0.420 |
Why?
|
Luminescent Agents | 1 | 2009 | 51 | 0.330 |
Why?
|
Spinal Neoplasms | 1 | 2015 | 716 | 0.320 |
Why?
|
Movement | 1 | 2015 | 1474 | 0.310 |
Why?
|
Organs at Risk | 2 | 2024 | 358 | 0.310 |
Why?
|
Quality Assurance, Health Care | 2 | 2016 | 2178 | 0.300 |
Why?
|
Lung | 1 | 2024 | 9989 | 0.250 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13249 | 0.250 |
Why?
|
Pancreatic Neoplasms | 1 | 2023 | 5333 | 0.250 |
Why?
|
Thoracic Neoplasms | 1 | 2023 | 265 | 0.190 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2023 | 3764 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36247 | 0.150 |
Why?
|
Brain Neoplasms | 1 | 2019 | 8984 | 0.150 |
Why?
|
Radiotherapy, Conformal | 2 | 2010 | 549 | 0.140 |
Why?
|
Radiation Injuries | 1 | 2023 | 1183 | 0.130 |
Why?
|
X-Rays | 1 | 2016 | 307 | 0.130 |
Why?
|
Immobilization | 1 | 2015 | 230 | 0.120 |
Why?
|
Radiation Dosage | 2 | 2023 | 1957 | 0.110 |
Why?
|
Reproducibility of Results | 4 | 2019 | 20048 | 0.100 |
Why?
|
Nanoparticles | 1 | 2023 | 1938 | 0.100 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2015 | 470 | 0.090 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2010 | 881 | 0.090 |
Why?
|
Stents | 1 | 2023 | 3303 | 0.090 |
Why?
|
Carbonic Anhydrase I | 1 | 2009 | 4 | 0.080 |
Why?
|
Carbonic Anhydrase II | 1 | 2009 | 22 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2023 | 3217 | 0.080 |
Why?
|
Calibration | 1 | 2010 | 816 | 0.070 |
Why?
|
Models, Chemical | 1 | 2010 | 614 | 0.070 |
Why?
|
Water | 2 | 2010 | 1402 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2023 | 4312 | 0.070 |
Why?
|
Macromolecular Substances | 1 | 2009 | 1433 | 0.070 |
Why?
|
Retrospective Studies | 3 | 2024 | 80301 | 0.070 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2009 | 511 | 0.070 |
Why?
|
Humans | 12 | 2024 | 760261 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5248 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2022 | 6310 | 0.060 |
Why?
|
Triazoles | 1 | 2009 | 904 | 0.050 |
Why?
|
Linear Models | 1 | 2010 | 5876 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11341 | 0.040 |
Why?
|
Prognosis | 1 | 2015 | 29636 | 0.030 |
Why?
|
Aged | 1 | 2024 | 168995 | 0.020 |
Why?
|
Film Dosimetry | 1 | 2010 | 29 | 0.020 |
Why?
|
Contrast Media | 1 | 2023 | 5301 | 0.020 |
Why?
|
Middle Aged | 1 | 2024 | 220175 | 0.020 |
Why?
|
Polycyclic Compounds | 1 | 2009 | 29 | 0.020 |
Why?
|
Calorimetry | 1 | 2009 | 129 | 0.020 |
Why?
|
Xenon Isotopes | 1 | 2009 | 66 | 0.020 |
Why?
|
Male | 2 | 2024 | 359413 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2014 | 1256 | 0.020 |
Why?
|
Computer-Aided Design | 1 | 2010 | 301 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7072 | 0.020 |
Why?
|
Time Factors | 1 | 2009 | 40133 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2010 | 848 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2009 | 706 | 0.020 |
Why?
|
Materials Testing | 1 | 2010 | 858 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9274 | 0.020 |
Why?
|
Female | 1 | 2024 | 391011 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2010 | 14656 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2014 | 5201 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 6965 | 0.010 |
Why?
|
Biosensing Techniques | 1 | 2009 | 679 | 0.010 |
Why?
|
Equipment Design | 1 | 2010 | 3520 | 0.010 |
Why?
|
Kinetics | 1 | 2009 | 6378 | 0.010 |
Why?
|
Sulfonamides | 1 | 2009 | 1973 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54263 | 0.010 |
Why?
|
Models, Molecular | 1 | 2009 | 5429 | 0.010 |
Why?
|
Computer Simulation | 1 | 2010 | 6210 | 0.010 |
Why?
|
Algorithms | 1 | 2010 | 13967 | 0.010 |
Why?
|
Concepts
(82)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_